CDKN1A and cancer: p21, encoded by CDKN1A gene, was first identified as a CDK regulator that suppresses cell cycle G1/S phase and retinoblastoma protein (RB) phosphorylation (65). For its profound role in halting cellular proliferation, p21 usually acts as a tumor suppressor and is implicated in response to many cancer treatments (65, 66).